Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dutasteride and finasteride affect different cell types differently.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Male pattern baldness involves hormones and cell signals affecting hair growth.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

PTH-CBD agonists may help regrow hair after chemotherapy.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

A genetic mutation caused severe rickets and alopecia in an Indian patient, but high-dose calcium and phosphate treatment improved their condition.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

A gene called BMAL1 plays a role in controlling hair growth.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

No medications for alcohol dependence have been approved for marketing yet.

A 5% concentration of Dorema aucheri extract significantly improves diabetic wound healing.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Androgens can help prevent memory problems caused by apoE4.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.